2. Gene
  3. Idh2 - isocitrate dehydrogenase 2 (NADP+), mitochondrial Gene

Idh2 - isocitrate dehydrogenase 2 (NADP+), mitochondrial Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Mus musculus

Also known as IDPm; Idh-2; E430004F23

Gene ID: 269951 | Gene type: protein coding

About Idh2

Chromosome 7: 79,744,594-79,765,140 reverse strand.GRCm39:CM001000.3

This gene has 7 transcripts (splice variants), 261 orthologues, 1 paralogue and is associated with 9 phenotypes. Broad expression in heart adult (RPKM 329.1), kidney adult (RPKM 134.6) and 22 other tissues.

Summary

Enables isocitrate dehydrogenase (NADP+) activity. Predicted to be involved in several processes, including NADP biosynthetic process; isocitrate metabolic process; and negative regulation of matrix metallopeptidase secretion. Predicted to act upstream of or within glyoxylate cycle and tricarboxylic acid cycle. Located in cytosol and peroxisome. Is expressed in several structures, including alimentary system; brain; genitourinary system; respiratory system; and sensory organ. Human ortholog(s) of this gene implicated in D-2-hydroxyglutaric aciduria 2; acute myeloid leukemia; carcinoma (multiple); and lung Cancer (multiple). Orthologous to human IDH2 (isocitrate dehydrogenase (NADP(+)) 2). [provided by Alliance of Genome Resources, Apr 2022]

Idh2 Products(1)

mRNA Protein Name
NM_173011.2 NP_766599.2 isocitrate dehydrogenase [NADP], mitochondrial precursor

Idh2 Protein Structure

PTZ00435

PTZ00435: PTZ00435 (38 - 450)

  • 0
  • 100
  • 200
  • 300
  • 400
  • 452 a.a.
Protein Preferred Names Protein Names

isocitrate dehydrogenase [NADP], mitochondrial

ICD-M

IDH

IDP

NADP(+)-specific ICDH

NADP+-specific isocitrate dehydrogenase

oxalosuccinate decarboxylase

Related Agents

Approval
Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-18690 Enasidenib Inhibitor 99.97% Yes
HY-18690A Enasidenib mesylate Inhibitor 99.85% Yes
Clinical Phase
Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-104042 Vorasidenib Inhibitor 99.87% Phase 3
Pre-clinical Phase
Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-131312 LY3410738 Inhibitor / Unkown
HY-149359 IHMT-IDH1-053 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Idh2 NCBI NCBI:3418